The University of Southampton
University of Southampton Institutional Repository

The novel UDP Glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution

The novel UDP Glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution
The novel UDP Glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution
The human UDP glycosyltransferase (UGT) 3A family is one of three families involved in the metabolism of small lipophilic compounds. Members of these families catalyze the addition of sugar residues to chemicals, which enhances their excretion from the body. The UGT1 and UGT2 family members primarily use UDP glucuronic acid to glucuronidate numerous compounds, such as steroids, bile acids, and therapeutic drugs. We showed recently that UGT3A1, the first member of the UGT3 family to be characterized, is unusual in using UDP N-acetylglucosamine as sugar donor, rather than UDP glucuronic acid or other UDP sugar nucleotides (J Biol Chem 283:36205–36210, 2008). Here, we report the cloning, expression, and characterization of UGT3A2, the second member of the UGT3 family. Like UGT3A1, UGT3A2 is inactive with UDP glucuronic acid as sugar donor. However, in contrast to UGT3A1, UGT3A2 uses both UDP glucose and UDP xylose but not UDP N-acetylglucosamine to glycosidate a broad range of substrates including 4-methylumbelliferone, 1-hydroxypyrene, bioflavones, and estrogens. It has low activity toward bile acids and androgens. UGT3A2 transcripts are found in the thymus, testis, and kidney but are barely detectable in the liver and gastrointestinal tract. The low expression of UGT3A2 in the latter, which are the main organs of drug metabolism, suggests that UGT3A2 has a more selective role in protecting the organs in which it is expressed against toxic insult rather than a more generalized role in drug metabolism. The broad substrate and novel UDP sugar specificity of UGT3A2 would be advantageous for such a function.
0026-895X
472-478
MacKenzie, P.I.
0885e4f8-3fca-4f4e-9e4f-985221f9ca43
Rogers, A.
105eeebc-1899-4850-950e-385a51738eb7
Elliot, D.J.
7a8a0279-de6d-4217-afc7-9606412f310e
Chau, N.
90c15167-e4fe-4792-9aa0-0fea0b8280f0
Hulin, J.-A.
1866d66a-0404-4fde-aaa1-59b3e672cb40
Miners, J.O.
6a00c6e1-7a72-4740-918c-3c2627eaa6e4
Meech, R.
53ff95d1-295b-4794-8082-14a6c86735be
MacKenzie, P.I.
0885e4f8-3fca-4f4e-9e4f-985221f9ca43
Rogers, A.
105eeebc-1899-4850-950e-385a51738eb7
Elliot, D.J.
7a8a0279-de6d-4217-afc7-9606412f310e
Chau, N.
90c15167-e4fe-4792-9aa0-0fea0b8280f0
Hulin, J.-A.
1866d66a-0404-4fde-aaa1-59b3e672cb40
Miners, J.O.
6a00c6e1-7a72-4740-918c-3c2627eaa6e4
Meech, R.
53ff95d1-295b-4794-8082-14a6c86735be

MacKenzie, P.I., Rogers, A., Elliot, D.J., Chau, N., Hulin, J.-A., Miners, J.O. and Meech, R. (2011) The novel UDP Glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution. Molecular Pharmacology, 79 (3), 472-478. (doi:10.1124/mol.110.069336). (PMID:21088224)

Record type: Article

Abstract

The human UDP glycosyltransferase (UGT) 3A family is one of three families involved in the metabolism of small lipophilic compounds. Members of these families catalyze the addition of sugar residues to chemicals, which enhances their excretion from the body. The UGT1 and UGT2 family members primarily use UDP glucuronic acid to glucuronidate numerous compounds, such as steroids, bile acids, and therapeutic drugs. We showed recently that UGT3A1, the first member of the UGT3 family to be characterized, is unusual in using UDP N-acetylglucosamine as sugar donor, rather than UDP glucuronic acid or other UDP sugar nucleotides (J Biol Chem 283:36205–36210, 2008). Here, we report the cloning, expression, and characterization of UGT3A2, the second member of the UGT3 family. Like UGT3A1, UGT3A2 is inactive with UDP glucuronic acid as sugar donor. However, in contrast to UGT3A1, UGT3A2 uses both UDP glucose and UDP xylose but not UDP N-acetylglucosamine to glycosidate a broad range of substrates including 4-methylumbelliferone, 1-hydroxypyrene, bioflavones, and estrogens. It has low activity toward bile acids and androgens. UGT3A2 transcripts are found in the thymus, testis, and kidney but are barely detectable in the liver and gastrointestinal tract. The low expression of UGT3A2 in the latter, which are the main organs of drug metabolism, suggests that UGT3A2 has a more selective role in protecting the organs in which it is expressed against toxic insult rather than a more generalized role in drug metabolism. The broad substrate and novel UDP sugar specificity of UGT3A2 would be advantageous for such a function.

This record has no associated files available for download.

More information

e-pub ahead of print date: November 2010
Published date: March 2011
Organisations: Faculty of Health Sciences

Identifiers

Local EPrints ID: 366181
URI: http://eprints.soton.ac.uk/id/eprint/366181
ISSN: 0026-895X
PURE UUID: e3c7db4b-59b0-4a32-8f70-4cbe27c0a810

Catalogue record

Date deposited: 30 Jun 2014 09:44
Last modified: 14 Mar 2024 17:04

Export record

Altmetrics

Contributors

Author: P.I. MacKenzie
Author: A. Rogers
Author: D.J. Elliot
Author: N. Chau
Author: J.-A. Hulin
Author: J.O. Miners
Author: R. Meech

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×